International Stem Cell (ISCO) Current Leases (2019 - 2026)

International Stem Cell (ISCO) has reported Current Leases for 8 consecutive years, with $199000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Leases fell 46.36% year-over-year to $199000.0 in Q2 2026; TTM through Jun 2026 was $199000.0, a 46.36% decrease from a year earlier, with the FY2025 full-year figure at $393000.0, up 19.09% from the prior year.
• Current Leases was $199000.0 for Q2 2026 at International Stem Cell, down from $393000.0 in the prior quarter.
• Over five years, Current Leases peaked at $393000.0 in Q4 2025 and troughed at $196000.0 in Q1 2022.
• A 5-year average of $283941.2 and a median of $276000.0 in 2023 frame the typical range for Current Leases.
• Across the five-year window, Current Leases rose 28.49% in 2022 and plunged 46.36% in 2026, its largest moves.
• Over 5 years, Current Leases stood at $230000.0 in 2022, then grew by 20.0% to $276000.0 in 2023, then climbed by 19.57% to $330000.0 in 2024, then grew by 19.09% to $393000.0 in 2025, then slumped by 49.36% to $199000.0 in 2026.
• The last three Current Leases figures came in at $199000.0 (Q2 2026), $393000.0 (Q4 2025), and $383000.0 (Q3 2025), per Business Quant data.